LPIN1 genetic variation is associated with rosiglitazone response in type 2 diabetic patients. (Q46436094)
Jump to navigation
Jump to search
scientific article published on 9 August 2008
Language | Label | Description | Also known as |
---|---|---|---|
English | LPIN1 genetic variation is associated with rosiglitazone response in type 2 diabetic patients. |
scientific article published on 9 August 2008 |
Statements
LPIN1 genetic variation is associated with rosiglitazone response in type 2 diabetic patients (English)
Se Eun Park
So Hun Kim
Kyung Sub Kim
Hyun Chul Lee
9 August 2008
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference